FDA Approves Basilea's Zevtera Antibiotic For Three Different Uses; Stock Up

The U.S. Food and Drug Administration has approved Basilea Pharmaceutica International Ltd.'s new Zevtera Antibiotic (ceftobiprole medocaril sodium for injection) for three different bacterial infections. Following the

Merck Begins Phase 3 Trial Of MK-1084 As First-Line Treatment Of Certain Metastatic NSCLC Patients

Merck & Co. Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Thursday it has initiated a Phase 3 clinical trial evaluating MK-1084, an investigational oral selective KRAS G12C inhibitor, in combination

AngioDynamics Q3 Loss Sharply Widens; Slashes FY24 Outlook

While reporting financial results for the third quarter on Thursday, medical devices company AngioDynamics, Inc. (ANGO) slashed its adjusted loss and net sales guidance for the full year 2024, reflecting the recent

Spotify Technology Appoints Christian Luiga As New CFO

Spotify Technology S.A. (SPOT) announced Thursday the appointment of Christian Luiga as its new Chief Financial Officer. The company currently plans for Luiga to join in third quarter of 2024.

Conagra Brands Reaffirms FY24 Outlook - Update

While reporting financial results for the third quarter on Thursday, branded food company Conagra Brands, Inc. (CAG) reaffirmed its adjusted earnings and organic net sales growth guidance for the full-year 2024.

Bay Street May Open Slightly Higher

Canadian shares may open slightly higher Thursday morning, tracking positive cues from global markets. However, the market is unlikely to see any substantial move up north due to subdued commodities markets and caution

Boston Scientific Says FTC Issues Second Request Amid Boston Scientific And Axonics Merge Review

Boston Scientific Corp. (BSX) revealed Thursday in a Form 8-K filing with the U.S. Securities and Exchange Commission that the company and Axonics each received a request for additional information from the U.S. Federal

Acumen Pharma Partners Lonza To Advance Sabirnetug For Alzheimer's Disease Treatment

Biopharmaceutical company Acumen Pharmaceuticals, Inc. (ABOS) on Thursday signed a collaboration agreement with Lonza, a global partner to the pharmaceutical, biotech and nutraceutical markets.

U.S. Weekly Jobless Claims Rise More Than Expected

A day ahead of the release of the more closely watched monthly jobs report, the Labor Department released a report on Thursday showing first-time claims for U.S. unemployment benefits rose by more than expected in the

U.S. Trade Deficit Unexpectedly Widens To $68.9 Billion In February

A report released by the Commerce Department on Thursday showed the U.S. trade deficit unexpectedly widened in the month of February.